Mountaingate exits healthcare commercialization platform Relevate
- Tim Pantello serves as CEO of Relevate
- Relevate was founded in 2007 as Healthcare Regional Marketing
Mountaingate Capital has exited its investment in Relevate Health, a Cincinnati-based healthcare commercialization platform serving pharmaceutical, biotechnology, medical device and healthcare organizations.
Mountaingate first partnered with Relevate in 2020.
Tim Pantello serves as CEO of Relevate.
On the deal, Bruce Rogers, co-founder and managing director of Mountaingate, said in a statement, “It has been tremendously rewarding to support the world-class management team at Relevate as they executed the plan we collectively envisioned at the outset of our partnership. We have no doubt they will continue to set the standard within the pharmaceutical commercialization space and we look forward to following their next phase of growth.”
Relevate and Mountaingate were advised by Houlihan Lokey with Latham & Watkins serving as counsel in the transaction.
Relevate was founded in 2007 as Healthcare Regional Marketing.
